Literature DB >> 11914031

Somatic mutations in thyroid nodular disease.

Knut Krohn1, Ralf Paschke.   

Abstract

Thyroid nodules can be found in up to 50% of inhabitants of iodine-deficient areas and are classified as hot or cold thyroid nodules according to their scintigraphic characteristics. Studies of hot thyroid nodules with comparable mutation detection methods and screening at least exon 10 of the TSH receptor reported frequencies for somatic TSH-receptor mutations ranging from 20 to 82% in patients with similar iodine supply. We have recently screened 75 hot thyroid nodules for somatic TSH-receptor mutations with the more sensitive DGGE method and found somatic TSH-receptor mutations in 57% and Gsalpha mutations in 3%. As 50% of the mutation-negative nodules from female patients are of monoclonal origin when tested for X-chromosome inactivation somatic mutations in other genes are likely to cause the development of hot thyroid nodules. Scintigraphically nonsuppressible areas have been identified in up to 40% of euthyroid goiters in iodine-deficient areas. We recently identified somatic TSH-receptor mutations in microscopic autonomous areas with increased 125T uptake in euthyroid goiters studied by autoradiography 20 years ago. These constitutively activating somatic TSH-receptor mutations in minute autoradiographically hot areas of euthyroid goiters are very likely starting foci which most likely lead to toxic thyroid nodules in iodine-deficient goiters. Therefore iodine deficiency does not only lead to euthyroid goiters but also to thyroid autonomy. The latter is also suggested by epidemiologic studies. Similar mechanisms induced by iodine deficiency and the subsequent hyperplasia, mutagenesis, and selection of cell clones could also lead to cold thyroid nodules by somatic mutations that only initiate growth but not hyperfunction of the affected thyroid epithelial cell. Somatic ras mutations have frequently been detected in histologically characterized thyroid adenomas or adenomatous nodules. However, they seem to be rare in cold thyroid nodules. Since the majority of these latter nodules and 60% of the cold thyroid nodules are monoclonal other somatic mutations are likely in these nodules.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11914031     DOI: 10.1006/mgme.2001.3290

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  5 in total

Review 1.  How to define follicular thyroid carcinoma?

Authors:  Kurt Werner Schmid; Nadir Rashad Farid
Journal:  Virchows Arch       Date:  2006-02-28       Impact factor: 4.064

Review 2.  Thyrotropin receptor-associated diseases: from adenomata to Graves disease.

Authors:  Terry F Davies; Takao Ando; Reigh-Yi Lin; Yaron Tomer; Rauf Latif
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

3.  Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas.

Authors:  Davide Calebiro; Elisa S Grassi; Markus Eszlinger; Cristina L Ronchi; Amod Godbole; Kerstin Bathon; Fabiana Guizzardi; Tiziana de Filippis; Knut Krohn; Holger Jaeschke; Thomas Schwarzmayr; Rifat Bircan; Hulya Iliksu Gozu; Seda Sancak; Marek Niedziela; Tim M Strom; Martin Fassnacht; Luca Persani; Ralf Paschke
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

4.  8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through different mechanisms.

Authors:  Simona Lucchi; Davide Calebiro; Tiziana de Filippis; Elisa S Grassi; Maria Orietta Borghi; Luca Persani
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

Review 5.  Is there still a role for thyroid scintigraphy in the workup of a thyroid nodule in the era of fine needle aspiration cytology and molecular testing?

Authors:  Rodrigo Moreno-Reyes; Aglaia Kyrilli; Maria Lytrivi; Carole Bourmorck; Rayan Chami; Bernard Corvilain
Journal:  F1000Res       Date:  2016-04-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.